BENJAMIN JEPPE: Open Payments
NPI 1598702367 · ROSEBURG, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$256 in 12 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $214 · 2025 $256
Food & beverage: $256
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $61 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| PFIZER INC. | 2 | $40 |
| ABBVIE INC. | 2 | $36 |
| Madrigal Pharmaceuticals | 2 | $35 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
| Edwards Lifesciences Corporation | 1 | $15 |
Products named: TRELEGY ELLIPTA, LEQVIO, PREVNAR 20, VRAYLAR, REZDIFFRA, ZENPEP, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve.
Industry payments across OR — which companies pay providers there.
